Citigroup’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.3K | Sell |
14,748
-8,579
| -37% | -$34.5K | ﹤0.01% | 3943 |
|
|
2025
Q1 | $80.9K | Sell |
23,327
-1,597
| -6% | -$5.54K | ﹤0.01% | 3940 |
|
|
2024
Q4 | $164K | Buy |
24,924
+1,819
| +8% | +$12K | ﹤0.01% | 3698 |
|
|
2024
Q3 | $209K | Buy |
23,105
+11,560
| +100% | +$105K | ﹤0.01% | 3552 |
|
|
2024
Q2 | $185K | Sell |
11,545
-37,632
| -77% | -$604K | ﹤0.01% | 3195 |
|
|
2024
Q1 | $771K | Sell |
49,177
-42,712
| -46% | -$670K | ﹤0.01% | 2551 |
|
|
2023
Q4 | $1.23M | Buy |
+91,889
| New | +$1.23M | ﹤0.01% | 2000 |
|